bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 6, 2024
ABSTRACT
Vaccines
remain
a
vital
public
health
tool
to
reduce
the
burden
of
COVID-19.
COVID-19
vaccines
that
are
more
closely
matched
circulating
SARS-CoV-2
lineages
elicit
potent
and
relevant
immune
responses
translate
improved
real-world
vaccine
effectiveness.
The
rise
in
prevalence
Omicron
JN.1
lineage,
subsequent
derivative
sublineages
such
as
KP.2
KP.3,
coincided
with
reduced
neutralizing
activity
effectiveness
XBB.1.5-adapted
vaccines.
Here,
we
characterized
biophysical
immunologic
attributes
BNT162b2
JN.1-
KP.2-adapted
mRNA
vaccine-encoded
spike
(S)
protein
immunogens.
Biophysical
interrogations
S
revealed
structural
consequences
hallmark
amino
acid
substitutions
potential
molecular
mechanism
escape
employed
by
KP.2.
candidates
were
evaluated
for
their
immunogenicity
when
administered
fourth
or
fifth
doses
BNT162b2-experienced
mice
primary
series
naïve
mice.
In
both
vaccine-experienced
settings,
conferred
over
XBB.1.5
against
broad
panel
emerging
sublineages,
including
predominant
KP.3.1.1
XEC
lineages.
Antigenic
mapping
indicated
greater
antigenic
overlap
currently
compared
an
vaccine.
CD4
+
CD8
T
cell
generally
conserved
across
all
three
Together,
data
support
selection
2024-25
formula.
ONE-SENTENCE
SUMMARY
encoding
prefusion
proteins
similar
preclinical
antibody
sublineage
pseudoviruses
than
those
elicited
past
iterations
licensed
vaccines,
thus
demonstrating
importance
annual
strain
changes
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 10, 2024
Summary
The
JN.1-sublineage
KP.3.1.1
recently
emerged
as
the
globally
prevalent
SARS-CoV-2
variant,
demonstrating
increased
infectivity
and
antibody
escape.
We
investigated
how
mutations
a
deletion
in
spike
protein
(S)
affect
ACE2
binding
Mass
spectrometry
revealed
new
glycan
site
at
residue
N30
altered
glycoforms
neighboring
N61.
Cryo-EM
structures
showed
that
rearrangement
of
adjacent
residues
did
not
significantly
change
overall
structure,
up-down
ratio
receptor-binding
domains
(RBDs),
or
binding.
Furthermore,
S
structure
with
hACE2
further
confirmed
an
epistatic
effect
between
F456L
Q493E
on
Our
analysis
shows
variants
after
late
2023
are
now
incorporating
reversions
to
found
other
sarbecoviruses,
including
glycan,
Q493E,
others.
Overall,
these
results
inform
structural
functional
consequences
mutations,
current
evolutionary
trajectory,
immune
evasion.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 6, 2024
ABSTRACT
Vaccines
remain
a
vital
public
health
tool
to
reduce
the
burden
of
COVID-19.
COVID-19
vaccines
that
are
more
closely
matched
circulating
SARS-CoV-2
lineages
elicit
potent
and
relevant
immune
responses
translate
improved
real-world
vaccine
effectiveness.
The
rise
in
prevalence
Omicron
JN.1
lineage,
subsequent
derivative
sublineages
such
as
KP.2
KP.3,
coincided
with
reduced
neutralizing
activity
effectiveness
XBB.1.5-adapted
vaccines.
Here,
we
characterized
biophysical
immunologic
attributes
BNT162b2
JN.1-
KP.2-adapted
mRNA
vaccine-encoded
spike
(S)
protein
immunogens.
Biophysical
interrogations
S
revealed
structural
consequences
hallmark
amino
acid
substitutions
potential
molecular
mechanism
escape
employed
by
KP.2.
candidates
were
evaluated
for
their
immunogenicity
when
administered
fourth
or
fifth
doses
BNT162b2-experienced
mice
primary
series
naïve
mice.
In
both
vaccine-experienced
settings,
conferred
over
XBB.1.5
against
broad
panel
emerging
sublineages,
including
predominant
KP.3.1.1
XEC
lineages.
Antigenic
mapping
indicated
greater
antigenic
overlap
currently
compared
an
vaccine.
CD4
+
CD8
T
cell
generally
conserved
across
all
three
Together,
data
support
selection
2024-25
formula.
ONE-SENTENCE
SUMMARY
encoding
prefusion
proteins
similar
preclinical
antibody
sublineage
pseudoviruses
than
those
elicited
past
iterations
licensed
vaccines,
thus
demonstrating
importance
annual
strain
changes